Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay

Journal of Virological Methods

Volumn 101, Issue 1-2, 2002, Pages 159-168

  Ross, R S ^a   Viazov, S ^a   Sarr, S ^a   Hoffmann, S ^a   Kramer, A ^a   Roggendorf, M ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Branched DNA assays; HCV genotype; Hepatitis C virus; Interferon ribavirin treatment; Routine diagnostic laboratory; Viral load

Indexed keywords

ALPHA INTERFERON; DNA BASE; RIBAVIRIN; VIRUS RNA;

ACCURACY; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CALIBRATION; CONTROLLED STUDY; DNA DETERMINATION; ENZYME IMMUNOASSAY; FEMALE; GENE AMPLIFICATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; CHILD; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VARIATION (GENETICS);

HEPATITIS C VIRUS;

EID: 0036175978     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(01)00433-5     Document Type: Article

References (42)

1. Epidemiology of hepatitis C
2. Comparative evaluation of the Quantiplex HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the Amplicor HIV-1 Monitor v1.5 test for quantitation of human immunodeficiency virus type 1 RNA in plasma
3. Biometrical methods
4. Evaluation of hepatitis C virus RNA RT/PCR qualitative and quantitative second generation assays
5. Evaluation of quantitative measurements of hepatitis C virus RNA to predict sustained response to interferon by genotype
6. Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome
7. The scientific challenge of hepatitis C
8. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology
9. Preparation of genotype-specific HCV RNA transcripts for assessing HCV detection and quantification assays
10. Second generation of the automated Cobas Amplicor HCV assay improves sensitivity of hepatitis C RNA detection and yields results that are more clinically relevant
11. EASL international consensus conference on hepatitis C. Consensus statement
12. Decline of hepatitis C virus load in serum during the first 24h after administration of interferon-beta as a predictor of the efficacy of therapy
13. Mother-to-child transmission of hepatitis C virus: Evidence for preventable peripartum transmission
14. Standardization of hepatitis C virus-RNA quantification: Advances and unfinished business
15. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2 and 3 by Quantiplex HCV RNA assays versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method
16. Serum HCV RNA levels assessed by quantitative NASBA: Stability of viral load over time, and lack of correlation with liver disease
17. Hepatitis C in pregnancy
18. Comparison of quantitative HCV RNA assays in chronic hepatitis C
19. Standardized hepatitis C virus RNA panels for nucleic acid testing assays
20. Hepatitis C viral dynamics
21. Analysis of hepatitis C virus quasispecies populations by temperature gradient gel electrophoresis
22. Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and Monitor assays
23. A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C
24. Assessment of viral loads in patients with chronic hepatitis C with Amplicor HCV Monitor version 1.0, Cobas HCV Monitor version 2.0, and Quantiplex HCV RNA version 2.0 assays
25. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
26. Measuring hepatitis C viremia in clinical samples: Can we trust the assays?
27. Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification
28. Standardization of hepatitis C virus RNA quantification
29. Randomised trial of interferon alpha-2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
30. Comparison of 3 quantitative HCV RNA assays. Accuracy of baseline viral load to predict treatment outcome in chronic hepatitis C
31. Performance of an automated system for quantification of hepatitis C virus RNA
32. Risk of hepatitis C transmission from infected medical staff to patients: Model-based calculations in surgical settings
33. Performance characteristics of a transcription-mediated nucleic acid amplification assay for qualitative detection of hepatitis C virus RNA
34. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA
35. New perspectives in the diagnosis of hepatitis C
36. Typing of hepatitis C virus isolates by DNA enzyme immunoassay
37. Quantification of HCV RNA in clinical samples by branched DNA (bDNA) technology
38. Clinical application of Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA
39. Clinical evaluation of the automated Cobas Amplicor HCV Monitor test version 2.0 for quantifying serum hepatitis C RNA and comparison to the Quantiplex HCV version 2.0 test
40. Clinical implications of hepatitis C viral kinetics
41. Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a